| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes
1Departments of Biochemistry and 2Pathology, Boston University School of Medicine, Boston, Massachusetts
Submitted 27 October 2004 ; accepted in final form 7 January 2005
Peroxisome proliferator-activated receptor-
(PPAR) is considered to be one of the master regulators of adipocyte differentiation. PPAR2 is abundantly expressed in mature adipocytes and is elevated in the livers of animals that develop fatty livers. The aim of this study was to determine the ability of PPAR2 to induce lipid accumulation in hepatocytes and to delineate molecular mechanisms driving this process. The hepatic cell line AML-12 was used to generate a cell line stably expressing PPAR2. Oil Red O staining revealed that PPAR2 induces lipid accumulation in hepatocytes. This phenotype is accompanied by a selective upregulation of several adipogenic and lipogenic genes including adipose differentiation-related protein (ADRP), adipocyte fatty acid-binding protein 4, sterol regulatory element-binding protein-1 (SREBP-1), fatty acid synthase (FAS), and acetyl-CoA carboxylase, genes whose expression levels are known to increase in steatotic livers of ob/ob mice. Furthermore, the PPAR2-regulated induction of both SREBP-1 and FAS parallels an increase in de novo triacylglycerol synthesis in hepatocytes. Triacylglycerol synthesis and lipid accumulation are further enhanced by culturing hepatocytes with troglitazone in the absence of exogenous lipids. These results correspond with an increase in the lipid droplet protein, ADRP, and the data demonstrate that ADRP functions to coat lipid droplets in hepatocytes as observed by confocal microscopy. Taken together, these observations propose a role for PPAR2 as an inducer of steatosis in hepatocytes and suggest that this phenomenon occurs through an induction of pathways regulating de novo lipid synthesis.
adipose differentiation-related protein; lipid droplets; nonalcoholic fatty liver disease; steatosis; triacylglycerol; peroxisome proliferator-activated receptor-2
This article has been cited by other articles:
|
|
 |
|
  C. Beysen, E. J. Murphy, H. Nagaraja, M. Decaris, T. Riiff, A. Fong, M. K. Hellerstein, and P. J. Boyle A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes J. Lipid Res., December 1, 2008; 49(12): 2657 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Varela, D. A. Antwi, R. Dhir, X. Yin, N. S. Singhal, M. J. Graham, R. M. Crooke, and R. S. Ahima Inhibition of ADRP prevents diet-induced insulin resistance Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G621 - G628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Wederell, M. Bilenky, R. Cullum, N. Thiessen, M. Dagpinar, A. Delaney, R. Varhol, Y. Zhao, T. Zeng, B. Bernier, et al. Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing Nucleic Acids Res., August 1, 2008; 36(14): 4549 - 4564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bell, H. Wang, H. Chen, J. C. McLenithan, D.-W. Gong, R.-Z. Yang, D. Yu, S. K. Fried, M. J. Quon, C. Londos, et al. Consequences of Lipid Droplet Coat Protein Downregulation in Liver Cells: Abnormal Lipid Droplet Metabolism and Induction of Insulin Resistance Diabetes, August 1, 2008; 57(8): 2037 - 2045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Bruno, C. E. Dugan, J. A. Smyth, D. A. DiNatale, and S. I. Koo Green Tea Extract Protects Leptin-Deficient, Spontaneously Obese Mice from Hepatic Steatosis and Injury J. Nutr., February 1, 2008; 138(2): 323 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, L. Qiang, and S. R. Farmer Identification of a Domain within Peroxisome Proliferator-Activated Receptor {gamma} Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in Adipocytes Mol. Cell. Biol., January 1, 2008; 28(1): 188 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Westerbacka, M. Kolak, T. Kiviluoto, P. Arkkila, J. Siren, A. Hamsten, R. M. Fisher, and H. Yki-Jarvinen Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects Diabetes, November 1, 2007; 56(11): 2759 - 2765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Qiang, H. Wang, and S. R. Farmer Adiponectin Secretion Is Regulated by SIRT1 and the Endoplasmic Reticulum Oxidoreductase Ero1-L{alpha} Mol. Cell. Biol., July 1, 2007; 27(13): 4698 - 4707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Erhuma, A. M. Salter, D. V. Sculley, S. C. Langley-Evans, and A. J. Bennett Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1702 - E1714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Dalen, S. M. Ulven, B. M. Arntsen, K. Solaas, and H. I. Nebb PPAR{alpha} activators and fasting induce the expression of adipose differentiation-related protein in liver J. Lipid Res., May 1, 2006; 47(5): 931 - 943. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
